Algernon Pharmaceuticals Inc (AGNPF)

[jb1965]

It is no longer a question of if FAIMS works. Current prototype able to measure at level of PPM - Parts Per Million. Which is all you need for disease detection.

The challenge now is to pick an area of interest and dedicate resources in applying FAIMS to address that area. Given limited resources the company can't do everything at once. It needs to find a niche. It can contemplate licensing technology to others for alternative applications.

JB